Stock Track | Astronics Corporation Soars Nearly 8% After-Hours on Strong Q4 Results and Upbeat 2025 Outlook

Stock Track
05 Mar

Astronics Corporation (NASDAQ: ATRO) saw its stock soar nearly 8% in the after-hours trading session on Tuesday after reporting robust financial results for the fourth quarter of 2024 and providing an upbeat outlook for 2025.

The aerospace and defense company's sales for the quarter increased by 6.8% year-over-year to $208.54 million, exceeding analysts' estimates of $194.91 million. Astronics' adjusted earnings per share of $0.48 also surpassed the consensus estimate of $0.19, reflecting a significant improvement compared to the prior year.

The company's strong performance was driven by continued growth in its Aerospace segment, which saw a 11.7% increase in sales to $188.5 million. The segment's operating profit rose to $16.8 million, or 8.9% of sales, supported by higher demand from the Commercial Transport market and improving production efficiencies.

Astronics' backlog reached a record $599.2 million at the end of 2024, providing a solid foundation for future growth. The company expects revenue for 2025 to range between $820 million and $860 million, with the midpoint representing a 6% increase over 2024 sales.

Peter J. Gundermann, Chairman, President, and Chief Executive Officer of Astronics, expressed optimism about the company's prospects, stating, "We begin the year with a strengthened balance sheet, an improving margin profile, and a record backlog. The signs are strong that 2025 will be a very good year for the Company."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10